[Treatment of mouth dryness following radiotherapy of head and neck tumors using Venalot].
D000328:Adult; D000368:Aged; D001566:Benzocaine / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D003374:Coumarins / Q000627:therapeutic use*; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects; D009062:Mouth Neoplasms / Q000532:radiotherapy; D009821:Oils / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects*; D012116:Resins, Plant / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use; D014987:Xerostomia / Q000188:drug therapy* / Q000209:etiology
D003374:Coumarins; D005419:Flavonoids; D009821:Oils; D012116:Resins, Plant; D014803:Vitamin B Complex; D001566:Benzocaine
Zur Behandlung der Mundtrockenheit nach Strahlentherapie von Tumoren im Kopf- und Halsbereich mit Venalot.